Sitagliptin Pregnancy and Breastfeeding Warnings
Sitagliptin is also known as: Januvia
Sitagliptin Pregnancy Warnings
Reproduction studies in rats and rabbits with doses approximately 12 times the human exposure at the maximum recommended human dose (MRHD) did not impair fertility or harm the fetus. Teratogenicity was not observed at doses up to 30 and 20 times MRHD in rats and rabbits, respectively, although at doses up to 100 times MRHD, an increase in the incidence of rib malformations was observed. There are no adequate and well-controlled studies in pregnancy women. AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
AU and UK: Use is not recommended US: Use during pregnancy only if clearly needed. AU TGA pregnancy category: B3 US FDA pregnancy category: B Comments: In the US, Merck Sharp & Dohme Corporation maintains a pregnancy registry to monitor pregnancy outcomes of women exposed to this drug while pregnant; health care providers are encouraged to report any prenatal exposure (1-800-989-8999).
Sitagliptin Breastfeeding Warnings
This drug is secreted in the milk of lactating rats at milk to plasma ratio of 4:1. Pups of rats administered this drug at 1000 mg/kg/day from gestation day 6 through lactation day 20 showed reduced birth weight and postnatal weight gain (observed prior to and after weaning). No functional or behavioral toxicity was observed. Due to lack of human data, an alternate drug may be preferred.
US: Use caution AU and UK: Use is not recommended. Excreted into human milk: Unknown Excreted into animal milk: Yes The effects in the nursing infant are unknown
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.